Citation Impact

Citing Papers

Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
The repertoire of glycan determinants in the human glycome
2009
Silicon Micromachining to Tissue Engineer Branched Vascular Channels for Liver Fabrication
2000
The Design of Scaffolds for Use in Tissue Engineering. Part I. Traditional Factors
2001 Standout
Functional Behavior of Primary Rat Liver Cells in a Three-Dimensional Perfused Microarray Bioreactor
2002
Hepatocyte culture on biodegradable polymeric substrates
1991
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1992
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Antibodies against GM1 ganglioside affect K+ and NA+ currents in isolated rat myelinated nerve fibers
1995
Guillain-Barré syndrome after exposure to influenza virus
2010
Demyelination Induced in Aggregating Brain Cell Cultures by a Monoclonal Antibody Against Myelin/Oligodendrocyte Glycoprotein
1990
Hydrogels in Regenerative Medicine
2009 Standout
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Identification of disialic acid-containing glycoproteins in mouse serum: a novel modification of immunoglobulin light chains, vitronectin, and plasminogen
2006
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Hepatocyte behavior within three-dimensional porous alginate scaffolds
2000
Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome
2003
Guillain-Barré syndrome
2016 Standout
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain–Barré syndrome
2008
The role of antioxidant nutrients in preventing hyperbaric oxygen damage to the retina
1989 StandoutNobel
Guillain–Barré Syndrome
2012 Standout
Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome
2005
Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes
2011
CRL-1072 Enhances Antimycobacterial Activity of Human Macrophages Through Interleukin-8
1999
Multiple N‐acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo‐oligosaccharide
2000
Biological roles of glycans
2016 Standout
Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis
2008 StandoutNobel
Resurgence of tuberculosis in children
1992 Standout
Mycobacterium tuberculosiscell envelope lipids and the host immune response
2004
Structural alterations in retinal tissues from rats deficient in vitamin E and selenium and treated with hyperbaric oxygen
1992 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Alginate: Properties and biomedical applications
2011 Standout
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
2000 Standout
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
2008
Ganglioside GM1 Mimicry inCampylobacterStrains from Sporadic Infections in the United States
1999
Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody
1992
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Hyperreflexia in Guillain-Barre syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody
1999
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Anti-GQ1b Ganglioside Antibody in Peripheral Nervous System Disorders
2004
Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels
1996
Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions
2004
Peripheral neuropathies and anti-glycolipid antibodies
2002
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
1988
Roles of lipoarabinomannan in the pathogenesis of tuberculosis
1999
Principles of lysosomal membrane degradation
2008
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons
1997
Cross-Reactive Antibodies against Gangliosides and Campylobacter jejuni Lipopolysaccharides in Patients with Guillaln-Barre or Miller Fisher Syndrome
1997
Association of IgM type anti‐GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy
1998
Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease
1996
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Guillain-Barré syndrome
2005 Standout
A case of anti-GA1 antibody-positive Fisher syndrome with elevated tau protein in cerebrospinal fluid
2011
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
2012
Asymmetric Total Synthesis of PDIM A: A Virulence Factor of Mycobacterium tuberculosis
2008 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
2015
Campylobacter jejunifrom Patients with Guillain-Barre Syndrome Preferentially Expresses a GD1a-Like Epitope
2002
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Mycobacterial virulence factors.
1996
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
Guillain-Barre Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM 1 and Anti-GQ 1b Antibodies in Rabbits
2001
Hydrogels for Tissue Engineering
2001 Standout
Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals.
1994
The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane.
1986
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Selection of a muramyl peptide based on its lack of activation of nuclear factor-κB as a potential adjuvant for AIDS vaccines
1992
Antipurified-Protein-Derivative Antibody in Tuberculous Pleural Effusions
1990 StandoutNobel
METABOLIC SUBSTRATE ENGINEERING AS A TOOL FOR GLYCOBIOLOGY
2002 StandoutNobel
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions
2000 Standout
Antecedent infections in Fisher syndrome
2005
Global Epidemiology of Campylobacter Infection
2015 Standout
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
1988 Standout
Nomenclature of monocytes and dendritic cells in blood
2010 Standout
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
2003 StandoutNobel
Mycobacterial virulence factors
1996
Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
2008 StandoutNobel
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
CSF filtration is an effective treatment of Guillain–Barre syndrome
2001
Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM 1 Ganglioside
1998
The Multiple Causes of Multiple Sclerosis: The Importance of Age of Infections in Childhood
1987 StandoutNobel
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.
1988
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay.
1987
Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections
1988
Severity of demyelination in vivo correlates with serum myelination inhibition activity in guinea pigs having a new form of experimental allergic encephalomyelitis
1986
Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?
1994
Studies on experimentally induced retinal degeneration. 1. Effect of lipid peroxides on electroretinographic activity in the albino rabbit
1982

Works of B. Schwerer being referenced

Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain–Barré syndrome
2000
Antiglycosphingolipid Immune Responses in Neurology: The Vienna Experience with Isotypes, Subclasses, and Diseasea
1998
Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy.
1999
Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE).
1984
Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen
1992
ANTISERA AGAINST GANGLIOSIDE GM2: IMMUNOCHEMICAL AND IMMUNOHISTOLOGICAL STUDIES
1982
Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome
1997
Pathogenetic Aspects of Demyelinating Lesions in Chronic Relapsing Experimental Allergic Encephalomyelitis: Possible Interaction of Cellular and Humoral Immune Mechanisms
1983
Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin
1986
Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome
1995
IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
1985
IgM and IgG Antibodies to Phenolic Glycolipid I from Mycobacterium leprae in Leprosy: Insight into Patient Monitoring, Erythema Nodosum Leprosum, and Bacillary Persistence
1986
LEUKOCYTE PPD‐PEROXIDASE ACTIVITY WITH POLYUNSATURATED FATTY ACID HYDROPEROXIDES: NORMAL VALUES IN BATTEN'S DISEASE
1978
Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of GuillainBarré syndrome
2002
Distinct Immunoglobulin Class and Immunoglobulin G Subclass Patterns against Ganglioside GQ1b in Miller Fisher Syndrome following Different Types of Infection
1999
Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis
1984
ELISA for determination of albumin in the nanogram range: Assay in cerebrospinal fluid and comparison with radial immunodiffusion
1987
Rankless by CCL
2026